abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of phosphodiesterase 4D. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding phosphodiesterase 4D. Methods of using these compounds for modulation of phosphodiesterase 4D expression and for treatment of diseases associated with expression of phosphodiesterase 4D are provided. |